from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0876c/-

LFCtreatmentdescriptionclass of inhibitor

-0.688

Amikacinug/mL Amikacintranslation

-0.327

Cap5-10ug/mL Capreomycintranslation

-0.676

Rox10-50 ug/mL Roxithromycintranslation

-1.023

SM2-5 ug/mL Streptomycintranslation

-0.902

Tet5-10 ug/mL Tetracyclinetranslation

0.003

Rif0.2-5ug/mL Rifampicintranscription

0.262

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.277

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.825

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.501

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.248

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.303

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.923

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.395

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.218

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.275

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.372

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.092

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.958

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.311

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.700

KCN5-20 ug/mL Potassium cyaniderespiration

0.368

NaN30.2-2 mM Sodium aziderespiration

-0.375

Nigericin50 uM Nigericinrespiration

0.884

TRC10-150 ug/mL Triclosanrespiration

-0.653

TRZ10-25 ug/mL Thioridazinerespiration

-2.012

Valinomycin0.5-10 uM Valinomycinrespiration

3.663

ZnSO42 mM ZnSO4respiration

0.033

menadione6-10 ug/mL Menadionerespiration

-0.497

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.486

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.452

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.636

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.253

NRP_1Non-replicating persistence stage 1dosRassociated

-0.018

Amp0.2mg/mL AmpicillincellWall

-0.045

Cephalexin20-100 ug/mL CephalexincellWall

0.040

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.210

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.688

EMB10-20 ug/mL EthambutolcellWall

-0.088

Eta12-40 ug/mL EthionamidecellWall

0.384

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.107

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.912

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.385

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.070

BZA0.12 mg/mL BenzamidearomaticAmides

1.649

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.244

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.000

H2O24 mM hydrogen peroxideDNAdamaging

0.233

Levo10 ug/mL LevofloxacinDNAdamaging

0.000

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.019

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.176

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.000

UVUV-irradiationDNAdamaging

-0.624

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.585

Antimycin12.5-50 ug/mL Antimycin A?

-0.392

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.595

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.707

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.237

PA8240.2-2 ug/mL PA-824?

1.266

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.221

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.251

Verapamil50 uM Verapamil?

-0.379

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.427

methoxatin10-20 ug/mL Methoxatin?